Abstract Complications related to preterm birth (PTB) and low birth weight (LBW) are leading causes of infant morbidity and mortality. Prenatal depression is a hypothesized psychosocial risk factor for both birth outcomes. The purpose of this systematic review was to examine evidence published between 1977 and 2013 on prenatal depression and risks of these primary adverse birth outcomes. A systematic search of the PUBMED and PsycINFO databases was conducted to identify studies testing the associations between prenatal depressive symptoms, or diagnoses of depression, and risk of PTB or LBW. We systematically selected 50 published reports on PTB and length of gestation, and 33 reports on LBW and BW. Results were reviewed by two independent reviewers and we evaluated the quality of the evidence with an established systematic review method, the Newcastle Ottawa Scale. We then undertook a narrative synthesis of the results following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Less than a quarter of 50 published reports found that prenatal depression was significantly associated with PTB or gestational age. In contrast, slightly more than half of the 33 reports found that prenatal depression was associated with LBW or BW. When weighing methodological features, we determined that the effects of prenatal depression on LBW are more consistent than effects on length of gestation or PTB. Although the evidence may not be strong enough to support routine depression screening for risk of adverse outcomes, screening to enable detection and timely treatment to reduce risk of postpartum depression is warranted. Further rigorous research on prenatal depression and adverse birth outcomes is needed.
Introduction
Preterm birth (PTB) is a global public health problem [1] . Approximately 15 million babies are born preterm each year world-wide, and the prevalence of PTB in the United States is approximately 13 %. Furthermore, approximately 8.2 % of infants in the U.S. in 2009 were born low birth weight (LBW), weighing less than 2,500 g [2] . The consequences include increased risk of mortality, health and developmental problems for infants and children, and emotional and economic costs for families [3] . Understanding the etiology and pathways to these two key adverse birth outcomes is of utmost importance [4] . Established risk factors for PTB include previous PTB, multiple gestation, chronic illnesses, smoking, infections, high or low pre-pregnancy weight, and early or advanced maternal age [5] . In the past three decades, research has also identified some psychosocial risk factors, particularly some forms of stress and prenatal anxiety [6] . However, the evidence is not yet definitive regarding whether prenatal depression is a clear risk factor for either PTB or LBW, which is the focus of this review.
The prevalence of depression during the second and third trimesters has been documented to be twice that as in the general female population [7] . Andersson et al. [8] determined that major depression was present in approximately 3 % and minor depression in 7 % of 1,795 pregnant women, and the majority were found to be undiagnosed and untreated. The trajectory of prenatal depression in 357 pregnant women was characterized by a U-shaped curve decreasing from first trimester (22.1 %) to second trimester (18.9 %) and then increasing again in the third trimester (21.6 %) [9] . More recently, McDonald et al. [10] reported that prenatal depressive symptoms (using the EPDS C13 cutoff) were present in 12 % of 3,024 women in the All Our Babies cohort. Major depression is associated with considerable suffering, disability, and lost productivity, and has been ranked by the World Health Organization as the single most burdensome disease in the world in terms of total disability-adjusted life years [11] . Depression during pregnancy has been associated with poorer maternal health behavior [12] and an increased risk of postpartum depression [13] .
Authors of prior literature reviews have remarked on the ''inconclusive and inconsistent'' evidence regarding links between prenatal depression and adverse birth outcomes [14] [15] [16] [17] [18] [19] [20] . We suspected that inconsistencies might be due to differences in methodology, sample size or composition, measurement and timing of depression assessment, and variation in whether studies accounted for potential confounds. Meta-analyses of this relatively small literature cannot easily take all of these design features into account. The specification of the birth outcome is also pertinent; that is, the most precise analyses distinguish spontaneous PTB (SPTB) from medicallyindicated birth, which prior reviews and meta-analyses have not generally highlighted. A previous meta-analysis of 29 studies found small though significant associations between prenatal depressive symptoms and PTB, LBW, or intrauterine growth restriction (IUGR) [14] . In this meta-analysis, studies were categorized into those using a continuous depression measure versus those with categorical variables in which researchers compare groups with little or no risk to groups at high-risk of depressive disorder. In studies examining no/low versus high-risk groups, effect sizes appear to be larger (pooled RRs: PTB = 1.39; LBW = 1.49; IUGR = 1.45) than in studies using a continuous depression measure (pooled RRs: PTB = 1.03; LBW = 1.04; IUGR = 1.02). Also, higher risks of adverse birth outcomes were evident in depressed women from developing countries and among depressed women of low SES in the U.S. However, this metaanalysis did not take into account critical design and methodological features in drawing conclusions about birth outcomes.
The present systematic review therefore addressed an important gap in the literature by qualitatively examining each study with respect to study design and methodological criteria using a formal system. Taking into account study quality, we seek to determine if prenatal depression predicts PTB or LBW and to identify specific methodological reasons for inconsistencies.
Methods
This systematic review utilized state-of-the-art methods per the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines [21] and performed quality assessments using the Newcastle Ottawa Scale (NOS) [22] .
Search Strategy
We conducted a systematic review of the PubMed and PsycINFO electronic databases for English language publications testing associations between depression and birth outcomes between April 1977 when the first publication appeared, and April 2013 (when we completed data collection and began the systematic review process). Keywords included depression, depressive disorder, prenatal, preterm, premature, prematurity, birth weight, low birth weight, small-for-gestational age, gestational age, fetal maturity, fetal growth retardation/restriction, and intrauterine growth retardation/restriction (see Appendix S1 for keyword combinations). Additional studies were identified by reviewing reference sections of retrieved articles.
Inclusion and Exclusion Criteria
Published observational studies were included if they used validated self-report screening tools to measure depressive symptoms during pregnancy, structured psychiatric interviews during pregnancy, or medical record chart review for current unipolar depression diagnoses. A published article had to include sufficient details on results on depressive symptoms/diagnosis and at least one birth outcome (PTB or GA, LBW or BW, small for gestational age, SGA, or IUGR) in order to be considered for inclusion. Some studies were not designed with the primary goal of testing prenatal depression and birth outcomes, but if relevant results were sufficiently described, they were included e.g. [23] [24] [25] [26] . Studies were excluded if they: (1) Measured prenatal depression after the birth of a child (retrospectively) [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] [42] [43] [44] [45] ; (2) Reported pre-pregnancy/postpartum depression [42] [43] [44] [45] [46] [47] ; (3) Did not use a reliable and/or valid measure of depression [48] [49] [50] [51] [52] [53] [54] [55] ; (4) Did not separate depression in analyses from antidepressant use [56] [57] [58] ; (5) Combined unipolar with bipolar depression (or other psychiatric diagnoses) [59] [60] [61] [62] [63] [64] [65] [66] [67] ; or (6) Reported the same data as a previous article [68] [69] [70] [71] [72] . Bipolar disorder and other psychiatric conditions were excluded from this systematic review due to their differing etiologies, treatments, and potential relationship to adverse birth outcomes compared to depression. Figure 1 provides an overview of the study selection and data extraction process per PRISMA guidelines [21] . Over 1,300 records were identified, and 142 full-text articles met sufficient criteria for detailed examination. Ninety-five fulllength articles met the full inclusion criteria for this systematic review, and 108 published findings were available in the 95 articles. The total number of findings is greater than the number of articles because a number of studies tested associations of depression with both LBW/BW and PTB/GA. In total, this review includes 50 published findings on PTB/GA from 47 articles, 33 findings on LBW/ BW from 29 articles, and 25 findings on SGA/IUGR from 19 articles.
Study Selection and Data Extraction
Study characteristics regarding design, sample, covariates, and timing and method of depression measurement were extracted (see Tables 1, 2, 3, 4) . In addition, we extracted information regarding whether the outcome was categorical (PTB, LBW) or continuous (GA, BW), and whether analyses were conducted for SPTB as a subset of all PTBs. One author conducted data extraction (EEA) and another verified it (AC). Discrepancies occurred in less than one quarter of results and were resolved through discussion with all authors.
Quality Assessment of Included Studies
Studies were also evaluated for methodological quality by two authors using the Newcastle-Ottawa Scale for Quality Assessment [22] . The NOS guidelines judge each study on three broad predefined criteria, some of which require further specification for the specific review: (1) the selection of the study groups (0-4 stars possible); (2) the comparability of the groups (0-2 stars possible); and (3) the ascertainment of either the exposure or outcome of interest for case-control or cohort studies respectively (0-3 stars possible). Study ratings then range from 0 to 9 stars. First, quality of selection refers to sample representativeness; selection and definition of control groups; and type of depression assessment. Second, quality of comparability refers to comparability of cases and controls on the basis of the design or analysis. For example, a study received one star for limiting the sample (e.g. excluding smokers), treating a key variable as an effect measure modifier (e.g. race/ethnicity), or statistically controlling for three or more key variables from at least two categories out of three. The categories of possible control variables were: (1) Medical risk factors (maternal age, parity, previous PTB, etc.); (2) Socio-demographic factors (race/ethnicity, education, etc.); and (3) Behavioral factors (smoking, alcohol, etc.). A study received one additional star if it controlled for at least one variable from each category and a total of four or more variables. Finally, quality of outcome refers to whether information on birth outcome variables were obtained from medical records or patient self report; when it was obtained; and the degree of followup of cases for birth outcomes data. For example, stars were given for use of medical records, birth weight obtained by scale measurements at time of birth, and better than 80 % follow up with description of those lost.
Disagreement between authors involved differences in interpretations of methods or results with consensus easily achieved in all cases through discussion. Studies with scores ranging from 1 to 3 were considered to be of low quality, those with scores of 4-6 of moderate quality, and studies with scores from 7 to 9 of high quality. Finally, although the NOS does not take sample size into account for quality ratings, we provide sample size information for the benefit of readers.
Definition of Exposure Variable
We included studies of diagnosed depression during pregnancy using criteria from the American Psychiatric Association's (APA) Diagnostic and Statistical Manual of Mental Disorders (DSM) or International Statistical Classification of Diseases (ICD-9 or ICD-10), both of which are widely used classification systems for mental disorders. Validated depression screening tools used in this literature included the Center for Epidemiological Studies Depression Scale (CES-D) [73] , Beck Depression Inventory (BDI) [74] , Edinburgh Postnatal Depression Scale (EPDS) [75] , General Health Questionnaire (GHQ) [76] , Hospital Anxiety and Depression Scale-Subset D (HADS-D) [77] , and the Brief Symptom Inventory (BSI) [78] . Two studies using a brief version of one screening tool (SCL-5), in which a majority of items address anxiety, were excluded [52, 53] . Although the EPDS and GHQ also include anxiety items, the majority of items are not anxiety-related and these screening tools are commonly used as to assess prenatal depression, thus they were not excluded.
Definition of Outcome Variables
PTB was defined according to convention as birth before the 37th week of gestation. Approximately half of PTBs can be categorized as the result of spontaneous preterm labor (SPTB), 30 % result from premature rupture of the membranes (PROM), and 20 % due to medically-induced births which have not been proposed to be associated with maternal depression and no literature on this category exists [79] . GA was defined as weeks of gestation at time of delivery and BW in grams. PTB and GA were determined by various methods including calculation from last menstrual period (LMP), ultrasound, and size by dates. Conventional definitions of LBW and SGA were used (2,500 g or less and weight below the 10th percentile for GA).
The most common definition of SGA refers to a weight below the 10th percentile for gestational age [80] . However, this definition does not make a distinction between infants constitutionally small versus growth-restricted, although a baby can be one or both. IUGR is defined as a condition in the third trimester when the baby is not gaining adequate weight. Fetal growth restriction (FGR), a synonym for IUGR, is the term used to designate a fetus that has not reached its growth potential because of genetic or environmental factors; FGR results in the birth of an infant who is small for gestational age (SGA) [81] .
Results
A total of 95 studies published between 1977 and 2013 met inclusion criteria. Among these were 76 studies on PTB/ GA and LBW/BW, including a total of 83 distinct findings that were extracted. Another 25 findings in 19 published articles were identified on prenatal depression in relation to SGA or IUGR. However, this set of studies was of substantially lower methodological quality compared to studies on PTB/LBW. For this reason, and to narrow the scope of the review, we excluded SGA and IUGR from our analysis (see Appendix S1), concentrating on the remaining 76 studies which are outlined in Tables 1, 2 , 3 and 4. Depression not significantly associated with LBW or VLBW Design A total of 63 of the 76 articles were observational studies and 13 were case-control design. As can be seen in Tables 1, 2 , 3 and 4, many of the investigations fulfilled criteria for moderate to high methodological quality (median NOS score = 7, range of 5-9). Studies with lower scores typically did not treat confounding variables extensively and/or had unclear information regarding attrition or depression assessment. Results were evaluated as significant if results of the key tests were p \ 0.05.
PTB and GA Outcomes
Fifty sets of findings related to PTB and/or GA were identified from 47 published studies. Tables 1 and 2 list the depression measures, timing of assessments, summary of findings, and NOS ratings for each study. Thirty-six of 50 reports targeted PTB as the outcome and exactly onequarter of the 36 (n = 9) report statistically significant associations with prenatal depression and PTB. For example, odds ratios range from 1.06 to 3.3 as can be seen in Table 1 . Of the 14 studies on GA, three reported statistically significant associations between prenatal depression whereas a majority did not. Additionally, four studies with high methodological quality [82] [83] [84] [85] analyzed both PTB and GA, two of which were case-control studies and two were prospective observational studies. Notably, none reported significant associations with prenatal depression. Because inconsistencies in previous reviews may be due to methodological differences, further results of the systematic review are organized into sections regarding the specific features of concern.
Important features: the following design elements from the studies are systematically reviewed in each section below 
Sample Size
Although it is important to consider, the NOS does not take sample size into account. The minimum sample size based on simple power analyses for a test of associations of depression and GA or BW would be about 400 to detect a small effect size with a minimum of 500 for analyses with multiple predictors. We therefore refer for our purposes to sample sizes \500 as 'small' and[500 as 'large.' Of the nine reports of significant associations between PTB and depression, a total Study did include GA in some analyses or as part of another outcome (i.e. small for gestational age, intrauterine growth restriction), but did not control for GA in the relevant analyses of eight had samples over 500 (NOS scores from 5 to 8). Odds ratios ranged from 1.3 to 1.96. Similarly, the large majority of the 27 studies reporting null findings had samples over 500 (20 of 27; NOS scores from 6 to 9). Overall, it appears that studies with large samples and better NOS ratings were more likely to report non-significant results. For example, a methodologically rigorous antidepressant study with the largest sample (n = 228,876) found that second trimester anti-depressant use, not depression diagnosis, predicted PTB [23] . The authors, however, did not conduct separate analyses for SPTB. Two additional studies with large samples and strong methodological quality [24, 86] did address SPTB, measured depressive symptoms using standardized methods, and conducted well-controlled analyses. However, neither found significant associations between prenatal depression and SPTB.
Of the three studies reporting significant associations between prenatal depression and GA, two had sample sizes less than 500. One additional high quality study [87] had a larger sample of 4,044 women. When adjusted for potential confounders, the association between major depressive symptoms (CES-D [23) and GA remained significant with a small effect size (-0.2 weeks) but there were no effects for PTB [87] . Of the 11 non-significant results for prenatal depression and GA (see Tables 1, 2) , most had relatively small samples. The largest sample of 7,697 was higher rated on quality, used the BSI screening tool, but yielded null results for both GA and PTB [82] .
SPTB
Of 13 published results, ten did not find an association between prenatal depression and SPTB (NOS scores from 6 to 9). Perkin et al. [88] , for instance, tested separate models for five different obstetric outcomes in a large sample of 1,515 pregnant women, and found no statistically significant associations between prenatal depression and either spontaneous or medically induced PTB.
Well-Controlled Studies
Of the 36 PTB reports, 26 included adequate or good control for known PTB risk factors. Of these, only 23 % (n = 6) found significant results whereas the majority (77 %, n = 20) did not. For example, Kramer et al. [89] controlled for 14 medical, socio-demographic and behavioral factors, and excluded women with major medical problems. They found that only pregnancy-specific anxiety independently predicted SPTB. The adjusted odds ratio for depression (CES-D C16) was 1.4 (95 % CI 1.0, 2.1), whereas the adjusted odds ratio was 1.8 (95 % CI 1.3, 2.4) for pregnancy-specific anxiety. Although pregnancyspecific anxiety, perception of high pregnancy risk, and depression remained significantly associated with spontaneous PTB in separate multiple logistic regression analyses, only pregnancy-related anxiety retained its association in logistic models containing all 3 measures [89] .
Of the 14 reports on prenatal depression and GA, eight included adequate controls. Of those eight, only two found significant associations, whereas six did not. Notably, in one of the rare studies to examine moderators, the authors reported a significant association of prenatal depression with fetal growth. Although they did not find a statistically significant association between prenatal depression and GA, they did find a significant association of prenatal depression and fetal growth in trimester-specific regression analyses in a subsample of over 200 women from lower occupational status households [90] .
Timing of Depression Assessment
Of the 50 PTB/GA reports, a majority (n = 37) assessed depression during the second and/or third trimesters, and another 13 assessed depression more than once including the first trimester. Of the 13 with early pregnancy data, only three compared trimesters. Of these, one found that first trimester depression was associated significantly with PTB [91] and two did not [92, 93] . Of the remaining ten that did not compare trimesters, most found that prenatal depression at an unspecified time in first to third trimester was not significantly associated with PTB/GA.
Diagnosed Depression
Of the 36 PTB reports, seven examined depression diagnoses. Notably, none of these studies found that diagnosed depression significantly predicted PTB [23, 24, 26, 85, 86, 94, 95] . Of the 14 reports on GA, six included depression diagnoses. Two of the 6 found that clinically diagnosed prenatal depression significantly predicted GA, although both had relatively small samples and one lacked adequate controls [96, 97] . Of the four that reported null results [85, [98] [99] [100] , three had small samples (\100), and only one adequately controlled for covariates.
Summary of PTB/GA Studies
In sum, individual PTB or GA studies that met most of the important methodological criteria were rare. Only two investigations with strong methodologies (one on PTB and one on GA) found significant results of depression, and another two PTB articles with strong methodologies reported no significant results. Thus, taking into account the methodological quality of studies, research on depression and PTB/GA is inconclusive at best.
LBW and BW Outcomes
Thirty-three published findings related to LBW and/or BW were identified from 29 studies (see Tables 3, 4) . Fifteen of 33 reports targeted LBW of which about half (53 %, n = 8 of 15) found that prenatal depression significantly predicted LBW. For example, odds ratios range from 1.4 to 3.6, as can be seen in Table 3 . Another 18 targeted BW in grams, and of these, one-third (n = 6 of 18) reported statistically significant inverse associations between prenatal depression and BW. Additionally, five of the 29 LBW studies reported results for both BW and LBW. Of these, three studies found that depression was significantly associated with both LBW and BW [101] [102] [103] , whereas two studies found no effects on either variable [82, 83] .
Sample Size
A majority of the studies on depression and LBW had larger samples sizes. Five of the eight studies that reported that prenatal depression significantly predicted LBW and six of the seven studies that did not find significant associations had samples over 500. The largest sample was composed of 14,175 racially-diverse pregnant women and results revealed significant associations between prenatal depression (measured by the EPDS) and incidence of LBW [104] . Although sample size was a major strength of this study, there were also weaknesses including the lack of key controls, namely pre-pregnancy BMI, antidepressant use, smoking and substance use [105] .
Well-Controlled Studies
The majority of the LBW reports (n = 11 of 15) included adequate controls for risk factors, yet only four of the 11 obtained significant results. The two highest quality studies, however, did report that women with prenatal depression were more likely to have LBW infants, and both involved depression diagnoses and adequately controlled for confounders [95, 103] . For example, in a sample of 1,100 racially diverse pregnant women, Rogal et al. [95] reported that women diagnosed with minor depression were more likely to give birth to an LBW infant (OR 1.82, 95 % CI 1.01, 3.29) . Of the 18 studies on continuous BW scores, 8 included adequate controls, but only two of eight found significant associations. Furthermore, eighteen studies predicted both LBW/BW and PTB/GA outcomes and were therefore capable of statistically controlling for gestational age in testing LBW. However, only 4 of the 18 studies did so. Two of the four were of highest quality (NOS = 9), [97, 106] but neither found that prenatal depression was associated with BW when controlling for GA. The other two studies that controlled for GA [100, 101] reported that prenatal depression significantly predicted both BW and LBW and, of note, they both used a more racially diverse sample. Earnshaw et al. [101] had the largest sample of the four studies (n = 420), but did not control for any other important risk factors (NOS = 6). Although Diego et al. [100] was high quality (NOS = 8), their sample was quite small (n = 79) and was not truly representative of the average pregnant community-dwelling resident. Unfortunately, close examination of all four studies does not clarify whether well-controlled studies with high quality methods are likely to find effects.
Timing of Depression Assessment
Of the 33 LBW/BW reports, a large majority (n = 25) assessed depression during the second and/or third trimester/s. Less than a third of these (n = 9 of 25) found significant results. Two more studies (of the 33) assessed depression at an unspecified time over all three trimesters and found that prenatal depression significantly predicted LBW [95, 107] . For example, Liu et al. [107] found that compared to women with no depressed mood (CES-D), infants born to women with severe depressed mood were more likely to be LBW (OR 3.6, 95 % CI 1.1,11.4). There were no effects, however, of moderate depressed mood. Furthermore, they found that this association was limited to infants born to African American women (OR 7.2, 95 % CI 1.8, 28.7) and was more pronounced in female infants (OR 7.5, 95 % CI 1.5, 38.9) [107] . The remaining 6 of the 33 studies with first trimester assessments reported no significant results.
Diagnosed Depression
Of the 15 LBW reports, only three involved diagnosed depression but two of three found that prenatal depression predicted incidence of LBW [95, 103] , whereas the other did not. Another seven of 18 studies examined diagnosed depression and infant BW continuously, and three of the seven found significant associations between prenatal depression and BW [96, 100, 101] whereas four did not (see Table 3 , 4).
Summary of LBW/BW Studies
Approximately half of the LBW and BW studies reported significant associations or odds ratios with prenatal depression. Of the four most precise and highest quality LBW studies controlling for GA, half report significant effects. However, on the whole, very few met most of the desirable methodological criteria. Indeed, only one LBW article had excellent methodology (large sample size and NOS = 9) and it reported no significant effects.
Discussion

Main Findings
Overall, in this systematic review, there were more published reports on PTB/GA than on LBW/BW. After dissection by study features, a clear pattern emerged showing that prenatal depression is rarely associated with PTB or GA in larger, well-controlled studies. Specifically, 75 % of published PTB findings from 1977 to 2013 did not obtain statistically significant associations with prenatal depression, no matter how it was measured. Significant associations were least likely for SPTB or for clinically-diagnosed depression. Many studies used relatively short screening tools to evaluate levels of depressive symptoms and cutoff scores for identifying clinically significant depressive symptoms. Although this practice is common, it does not equate with a clinical diagnosis by a structured interview. It is also important to note that screening tools that include many somatic symptoms characteristic of depression may produce artificially high scores in pregnancy due to somatic symptoms typical of pregnancy such as fatigue. Screening tools designed for the pregnancy period (like the EPDS) do not include such symptoms.
In contrast to the literature on PTB and GA, the LBW/ BW literature is characterized by fewer studies as a whole with ''small'' sample sizes, less well-controlled analyses, and fewer studies using validated clinical interviews. Nonetheless, we found that about half (53 %) of published LBW findings reported statistically significant associations with prenatal depression. Additionally, of the four most precise and highest quality LBW studies controlling for GA, again half report significant effects. This makes it hard to know if the ''glass is half full or half empty'' but it provides a clear sense of what evidence we now have and of what quality. With few exceptions, researchers have failed to control for time of delivery (GA) when predicting LBW which confounds length of gestation with fetal growth rate. The advantage of analyses that control for gestational age in testing LBW is to clarify mechanisms. If a baby is LBW and it is not due to shorter gestational length, then slower or impaired fetal growth was likely to be involved. Depressive symptoms in pregnancy were associated with birth weight controlling for timing of delivery in two of the four methodologically strong studies, but much less often with GA or PTB (25 % of studies). Furthermore, when examined by race/ethnicity of the participants, the results become more consistent for depression predicting LBW/BW. Specifically, three studies with samples of mostly non-Caucasian women all found significant inverse associations of prenatal depression and LBW/BW and no significant associations for PTB/GA [95, 100, 102] .
Interpretation
In contrast to some prior reviews, we used systematic methods (i.e. PRISMA guidelines and NOS ratings) and covered a longer time period and more recent published studies. This systematic review also excluded all studies which used retrospective assessment of prenatal depression (n = 20), studies using measures of depression that were clearly confounded with anxiety or stress, and studies that did not use a reliable or valid measure of depression. By excluding the large number of retrospective studies, this review helps to clarify inconsistencies in the literature further. We also refined our review by excluding studies that combined unipolar with bipolar depression (or other psychiatric diagnoses), and that grouped depression along with other ''high risk'' symptoms and behaviors. Thus, this review focused specifically on the very best evidence available, and finds that the evidence slightly favors an association between prenatal depression and LBW, and is much less clear for spontaneous PTB, let alone SGA which did not have as many, or as strong, a set of studies to review.
Among adequately controlled analyses reporting significant associations between prenatal depression and PTB, many were lower in methodological quality due to smaller sample size and lack of attention to whether the onset of labor was spontaneous or not. Additionally, the timing of depression diagnosis or screening differed between studies. We observed that studies including depression assessment during the first trimester resulted in fewer significant adverse outcomes (PTB or LBW) than depression assessed at later times in pregnancy, which may suggest that enduring or mid to late pregnancy depression has the greatest effects on fetal development. Vulnerable windows across gestation for adverse effects of prenatal depression may indicate that different mechanisms are operating at different times [108] . Mechanisms whereby depression in mid to late pregnancy affects fetal growth and ultimately BW are likely to involve health behaviors such as diet or physical activity [109] . Those affecting PTB via anxiety are frequently attributed to changes in the hypothalamicpituitary-adrenal (HPA) axis [110] . Inflammatory mechanisms may also be involved in both pathways as these mechanisms interact with one another and are not independent. These issues require further research.
Several recent reviews and meta-analyses have mentioned that untreated prenatal depression may have more detrimental effects on birth outcomes than antidepressant use [16] whereas others found antidepressants to be harmful [18] . Some of the most methodologically rigorous studies that we reviewed (NOS = 9) were antidepressant studies, most of which found that anti-depressant use-not depression-was associated with PTB e.g. [23, 24] . This fact underlines the importance of attending to medication use in any study of depression or depressive symptoms in pregnancy.
Strengths, Limitations and Research Directions
A strength of this systematic review is full attention to the methodological quality and characteristics of research designs. Because a majority of studies reported null findings, we are not as concerned with publication bias but it cannot be ruled out. Additionally, the studies reviewed here included women from countries other than North America and Europe and women of many races and ethnicities other than Caucasian. Some limitations include the paucity of randomized controlled trials (RCT) in this literature. Although several RCTs attempting to address prenatal depression have been published, only one recent study focused on preventing adverse birth outcomes by reducing depressive symptoms [111] . To do so, this study provided yoga and massage therapies and found decreases in depression and anxiety and longer gestational lengths and higher birth weight in the therapy groups than the no intervention control group. Therefore, future studies applying psychosocial and complementary treatments of depression to reduce PTB and LBW might clarify the picture if designed with state of the art RCT methods. Finally, an updated meta-analysis would be worthwhile as this literature continues to grow.
Implications for Practice
On the basis of the evidence reviewed here, depression screening with instruments that have been validated for use during pregnancy is merited at multiple time points throughout pregnancy-not just in the first trimester. Such a practice may enable detection and timely treatment to potentially reduce risk for adverse birth outcomes and certainly reduce risk of postpartum depression. Non-pharmacological treatments for depression, such as cognitive behavioral therapy [112, 113] and complementary treatments [111] can produce symptom relief with minimal sideeffects, although pharmacological treatments should not be ruled out where evidence suggests they are safe and if prescribed and monitored carefully. However, if referral and treatment systems are not in place and well-functioning, such screening is potentially unethical [114] . In the future, high quality prenatal care systems worldwide will develop the capacity for depression risk assessment and treatment in the context of monitoring pregnancies to successful birth.
Conclusion
In conclusion, the evidence on depression and birth outcomes is equivocal despite considerable attention to the topic. When considering only the highest quality studies, prenatal depression was implicated slightly more as a risk factor for LBW/BW than in spontaneous early labor and delivery, length of gestation, and PTB, and especially in racially diverse samples. In fact, other psychosocial factors such as stress and pregnancy anxiety have been documented more consistently as contributors in the complex etiology of PTB [110] . Of note, depression, anxiety, and stress are not synonymous phenomena and cannot be treated as such by researchers. Indeed, stress is usually defined in the literature in ways that are quite distinct from definitions of depression or anxiety [115, 116] . Furthermore, depressive and anxiety symptoms can occur independently of stress exposures, although they are known to be exacerbated by stressors. For example, in the stress diathesis model, high levels of stressors such as major negative life events are posited to contribute to the onset of affective disorders [117] . Also, the term ''distress'' is often confused with stress but it refers to negative affect in general, including anxiety, depression, and other negative mood states in the literature, and not to stress per se. Finally, the symptoms of anxiety and depression are not measured in the same ways as stress. Therefore, we suggest that future studies should be designed specifically to examine the links between prenatal depression and anxiety (distinct from stress) and adverse birth outcomes.
When studying depression, which was the focus of this review, future work must include validated screening tools for prenatal depression-not retrospectively assessed symptoms and not instruments designed to study depression in the postpartum period-and should control in the research design for the timing of depression assessments during pregnancy. Researchers are also advised to collect complete medical histories for preconception, prenatal medical risks, and obtain full information on health behaviors associated with risk for PTB or LBW. We recommend sampling ethnically diverse samples of at least 500 women in such studies. Finally, the most useful studies will control for gestational age when predicting LBW, and distinguish SPTB from medically-induced PTB when this is the primary outcome. The next generation of studies on prenatal depression and birth can help inform practice with respect to screening and interventions that are designed to increase the quality of life in pregnant women suffering with depression, and perhaps may help to reduce the likelihood of adverse birth outcomes and the effects on offspring.
